2021 Stock Pick of the Year
Plant-based baby nutrition stock could be bigger than Beyond Meat.

NYSE:AVLR - Avalara Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $186.36
  • Forecasted Upside: 10.85 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$168.12
▼ -0.68 (-0.40%)

This chart shows the closing price for AVLR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Avalara Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVLR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVLR

Analyst Price Target is $186.36
▲ +10.85% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Avalara in the last 3 months. The average price target is $186.36, with a high forecast of $210.00 and a low forecast of $155.00. The average price target represents a 10.85% upside from the last price of $168.12.

This chart shows the closing price for AVLR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
2021 Stock Pick of the Year
Plant-based baby nutrition stock could be bigger than Beyond Meat.

Current Consensus is Buy

The current consensus among 10 investment analysts is to buy stock in Avalara. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/4/2020
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/21/2021Evercore ISIBoost Price TargetPositive ➝ Outperform$180.00 ➝ $195.00Low
5/7/2021Morgan StanleyBoost Price TargetOverweight$170.00 ➝ $175.00High
5/7/2021Raymond JamesLower Price TargetOutperform$205.00 ➝ $155.00High
5/7/2021Canaccord GenuityLower Price TargetBuy$205.00 ➝ $165.00High
5/7/2021MizuhoLower Price TargetBuy$220.00 ➝ $180.00High
4/7/2021Morgan StanleyInitiated CoverageOverweight$170.00Medium
2/19/2021StephensReiterated RatingBuy$177.00High
2/11/2021Canaccord GenuityBoost Price TargetBuy$195.00 ➝ $205.00Low
2/11/2021Piper SandlerBoost Price TargetOverweight$195.00 ➝ $210.00Low
2/11/2021Needham & Company LLCBoost Price TargetBuy$190.00 ➝ $210.00Low
2/11/2021Raymond JamesBoost Price TargetOutperform$180.00 ➝ $205.00Low
2/11/2021MizuhoBoost Price TargetBuy$190.00 ➝ $220.00Low
1/27/2021Piper SandlerBoost Price TargetOverweight$185.00 ➝ $195.00High
12/30/2020Raymond JamesReiterated RatingBuyN/A
12/18/2020Evercore ISIInitiated CoverageOutperform$220.00Medium
12/9/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$195.00High
11/9/2020Smith Barney CitigroupBoost Price Target$167.00 ➝ $203.00High
11/6/2020Raymond JamesBoost Price TargetOutperform$140.00 ➝ $180.00Medium
11/6/2020MizuhoBoost Price TargetBuy$175.00 ➝ $190.00High
11/6/2020JMP SecuritiesBoost Price TargetOutperform$165.00 ➝ $185.00High
11/6/2020Needham & Company LLCBoost Price TargetBuy$150.00 ➝ $190.00High
11/6/2020Piper SandlerBoost Price TargetOverweight$138.00 ➝ $185.00Low
10/20/2020MizuhoBoost Price TargetOutperform ➝ Buy$150.00 ➝ $175.00Low
8/13/2020Raymond JamesBoost Price TargetOutperform$110.00 ➝ $140.00Low
7/20/2020Bank of AmericaReiterated RatingBuy$145.00High
6/24/2020Canaccord GenuityBoost Price TargetBuy$115.00 ➝ $150.00Low
6/24/2020The Goldman Sachs GroupBoost Price TargetBuy$117.00 ➝ $154.00Low
6/24/2020MizuhoBoost Price TargetBuy$120.00 ➝ $150.00Medium
6/24/2020JMP SecuritiesBoost Price TargetOutperform$106.00 ➝ $140.00Medium
6/24/2020Needham & Company LLCBoost Price TargetBuy$116.00 ➝ $150.00Medium
6/23/2020Stifel NicolausBoost Price TargetBuy$100.00 ➝ $140.00High
6/23/2020Piper SandlerBoost Price TargetOverweight$113.00 ➝ $138.00Medium
5/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$104.00 ➝ $120.00High
5/8/2020Needham & Company LLCBoost Price TargetBuy$90.00 ➝ $116.00High
5/8/2020JMP SecuritiesBoost Price TargetMarket Outperform$95.00 ➝ $106.00High
5/8/2020Raymond JamesBoost Price TargetOutperform$105.00 ➝ $110.00High
5/8/2020Piper SandlerBoost Price TargetOverweight$90.00 ➝ $113.00High
5/8/2020MizuhoBoost Price TargetBuy$85.00 ➝ $120.00High
5/8/2020Stifel NicolausBoost Price TargetBuy$95.00 ➝ $100.00High
4/13/2020Needham & Company LLCLower Price TargetBuy$100.00 ➝ $90.00Medium
3/31/2020Piper SandlerLower Price TargetOverweight$105.00 ➝ $90.00High
2/20/2020CitigroupInitiated CoverageBuy$120.00Low
2/17/2020Needham & Company LLCReiterated RatingBuy$100.00Low
2/14/2020StephensReiterated RatingOverweight$106.00Medium
2/13/2020Canaccord GenuityReiterated RatingBuy$100.00 ➝ $105.00High
2/13/2020Raymond JamesBoost Price TargetOutperform$95.00 ➝ $105.00High
2/13/2020MizuhoBoost Price TargetBuy$95.00 ➝ $105.00High
11/6/2019MizuhoReiterated RatingBuy$90.00 ➝ $95.00High
10/28/2019Piper Jaffray CompaniesInitiated CoverageOverweight$93.00Low
10/10/2019MizuhoInitiated CoverageBuy$90.00High
9/24/2019StephensSet Price TargetBuy$105.00High
9/15/2019KeyCorpSet Price TargetBuy$101.00Low
9/5/2019Raymond JamesInitiated CoverageOutperform$100.00 ➝ $100.00High
8/26/2019Canaccord GenuityInitiated CoverageBuy$100.00Medium
8/8/2019Bank of AmericaReiterated RatingBuy ➝ Buy$98.00 ➝ $100.00High
8/8/2019JPMorgan Chase & Co.Boost Price TargetOverweight$78.00 ➝ $104.00High
8/8/2019KeyCorpReiterated RatingOverweight$74.00 ➝ $101.00High
8/8/2019Needham & Company LLCBoost Price TargetBuy ➝ Buy$85.00 ➝ $100.00High
8/8/2019Stifel NicolausUpgradeHold ➝ Buy$52.00 ➝ $100.00High
8/7/2019William BlairInitiated CoverageOutperform ➝ Outperform$5.40High
7/30/2019StephensInitiated CoverageOverweight$105.00Low
7/26/2019First AnalysisInitiated CoverageStrong-BuyLow
5/10/2019Needham & Company LLCBoost Price TargetBuy ➝ Buy$64.00 ➝ $85.00Medium
5/8/2019KeyCorpBoost Price TargetOverweight$54.00 ➝ $74.00High
5/8/2019JMP SecuritiesBoost Price TargetMarket Outperform$49.00 ➝ $67.00High
4/11/2019Needham & Company LLCInitiated CoverageBuy$64.00High
2/13/2019JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$40.00 ➝ $49.00High
2/13/2019JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Positive$38.00 ➝ $64.00High
2/12/2019KeyCorpReiterated RatingOverweight ➝ Overweight$48.00 ➝ $54.00High
2/1/2019The Goldman Sachs GroupReiterated RatingBuy ➝ Buy$50.00Medium
1/7/2019KeyCorpReiterated RatingBuyHigh
1/7/2019Bank of AmericaUpgradeNeutral ➝ BuyHigh
12/13/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$30.08High
11/9/2018Bank of AmericaLower Price TargetNeutral ➝ Neutral$50.00 ➝ $42.00High
11/8/2018JMP SecuritiesUpgradeMarket Perform ➝ Outperform$40.00N/A
11/8/2018JPMorgan Chase & Co.Boost Price TargetNeutral$38.00N/A
10/14/2018KeyCorpReiterated RatingBuy$47.00Low
8/16/2018The Goldman Sachs GroupBoost Price TargetNeutral ➝ Buy$44.00High
7/10/2018The Goldman Sachs GroupInitiated CoverageNeutral$44.00High
7/10/2018JMP SecuritiesInitiated CoverageMarket PerformHigh
7/10/2018Stifel NicolausInitiated CoverageHold$44.00High
7/10/2018Bank of AmericaInitiated CoverageNeutral$55.00High
7/10/2018JPMorgan Chase & Co.Initiated CoverageNeutral$50.00High
7/10/2018KeyCorpInitiated CoverageSector Weight ➝ Sector WeightHigh
(Data available from 7/28/2016 forward)
Avalara logo
Avalara, Inc., together with its subsidiaries, provides cloud-based solutions for transaction tax compliance worldwide. The company offers a suite of compliance solutions that enable businesses to address the complexity of transaction tax compliance; process transactions in real time; produce detailed records of transaction tax determinations; and reduce errors, audit exposure, and total transaction tax compliance costs. The company's solutions include AvaTax, a solution for determining sales tax in the United States; Avalara Returns for tax return preparation, filing, and remittance; and Avalara Compliance Document Management solution, which creates, validates, stores, and manages sales tax exemption and reseller certificates. It also provides professional services, including nexus studies and analysis, voluntary compliance initiatives, tax registrations, and specialized tax research; MatrixMaster, a product taxability database for retail operations; Avalara CloudConnect, a hardware device for processing and storing transactions on-site for regularly scheduled uploads to AvaTax; Avalara Licensing, an online platform for business licenses and sales tax registrations; VAT Expert, a Web-based solution that checks the validity of customer and supplier value-added tax (VAT) numbers and provides VAT determinations in the form of invoices; and Brazilian tax compliance solutions that address the Brazilian transaction tax regimes through electronic compliance report validation, electronic invoice authentication and preparation, tax determination, and returns preparation; and Avalara Item Classification, a solution that addresses the process of assigning proper country-specific Harmonized System codes to products. The company was formerly known as Advantage Solutions, Inc. and changed its name to Avalara, Inc. in December 2005. Avalara, Inc. was incorporated in 1999 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $168.12
Low: $163.60
High: $170.00

50 Day Range

MA: $147.94
Low: $123.37
High: $168.80

52 Week Range

Now: $168.12
Low: $114.22
High: $185.37

Volume

717,343 shs

Average Volume

506,440 shs

Market Capitalization

$14.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Avalara?

The following Wall Street sell-side analysts have issued research reports on Avalara in the last twelve months: Canaccord Genuity, Evercore ISI, JMP Securities, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, Smith Barney Citigroup, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for AVLR.

What is the current price target for Avalara?

11 Wall Street analysts have set twelve-month price targets for Avalara in the last year. Their average twelve-month price target is $186.36, suggesting a possible upside of 10.9%. Needham & Company LLC has the highest price target set, predicting AVLR will reach $210.00 in the next twelve months. Raymond James has the lowest price target set, forecasting a price of $155.00 for Avalara in the next year.
View the latest price targets for AVLR.

What is the current consensus analyst rating for Avalara?

Avalara currently has 1 hold rating and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AVLR will outperform the market and that investors should add to their positions of Avalara.
View the latest ratings for AVLR.

What other companies compete with Avalara?

How do I contact Avalara's investor relations team?

Avalara's physical mailing address is 255 SOUTH KING STREET SUITE 1800, SEATTLE WA, 98104. The company's listed phone number is (206) 826-4900 and its investor relations email address is [email protected] The official website for Avalara is www.avalara.com.

2021 Stock Pick of the Year
Plant-based baby nutrition stock could be bigger than Beyond Meat.